GLOBAL PROSTATE SPECIFIC ANTIGEN (PSA) BIOMARKER MARKET 2021 BY COMPANY, REGIONS, TYPE AND APPLICATION, FORECAST TO 2026

Jul 2021 108
Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Prostate Specific Antigen (PSA) Biomarker
1.2 Classification of Prostate Specific Antigen (PSA) Biomarker by Type
1.2.1 Overview: Global Prostate Specific Antigen (PSA) Biomarker Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Prostate Specific Antigen (PSA) Biomarker Revenue Market Share by Type in 2020
1.2.3 Blood
1.2.4 Semen
1.2.5 Urine
1.3 Global Prostate Specific Antigen (PSA) Biomarker Market by Application
1.3.1 Overview: Global Prostate Specific Antigen (PSA) Biomarker Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Diagnostics
1.3.3 Drug Discovery
1.3.4 Personalized Medicine
1.3.5 Others
1.4 Global Prostate Specific Antigen (PSA) Biomarker Market Size & Forecast
1.5 Global Prostate Specific Antigen (PSA) Biomarker Market Size and Forecast by Region
1.5.1 Global Prostate Specific Antigen (PSA) Biomarker Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Prostate Specific Antigen (PSA) Biomarker Market Size by Region, (2016-2021)
1.5.3 North America Prostate Specific Antigen (PSA) Biomarker Market Size and Prospect (2016-2026)
1.5.4 Europe Prostate Specific Antigen (PSA) Biomarker Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Market Size and Prospect (2016-2026)
1.5.6 South America Prostate Specific Antigen (PSA) Biomarker Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Prostate Specific Antigen (PSA) Biomarker Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Prostate Specific Antigen (PSA) Biomarker Market Drivers
1.6.2 Prostate Specific Antigen (PSA) Biomarker Market Restraints
1.6.3 Prostate Specific Antigen (PSA) Biomarker Trends Analysis
2 Company Profiles
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business
2.1.3 Abbott Prostate Specific Antigen (PSA) Biomarker Product and Solutions
2.1.4 Abbott Prostate Specific Antigen (PSA) Biomarker Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Abbott Recent Developments and Future Plans
2.2 Siemens Healthcare
2.2.1 Siemens Healthcare Details
2.2.2 Siemens Healthcare Major Business
2.2.3 Siemens Healthcare Prostate Specific Antigen (PSA) Biomarker Product and Solutions
2.2.4 Siemens Healthcare Prostate Specific Antigen (PSA) Biomarker Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Siemens Healthcare Recent Developments and Future Plans
2.3 DiaSorin
2.3.1 DiaSorin Details
2.3.2 DiaSorin Major Business
2.3.3 DiaSorin Prostate Specific Antigen (PSA) Biomarker Product and Solutions
2.3.4 DiaSorin Prostate Specific Antigen (PSA) Biomarker Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 DiaSorin Recent Developments and Future Plans
2.4 Roche
2.4.1 Roche Details
2.4.2 Roche Major Business
2.4.3 Roche Prostate Specific Antigen (PSA) Biomarker Product and Solutions
2.4.4 Roche Prostate Specific Antigen (PSA) Biomarker Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Roche Recent Developments and Future Plans
2.5 Tosoh Bioscience
2.5.1 Tosoh Bioscience Details
2.5.2 Tosoh Bioscience Major Business
2.5.3 Tosoh Bioscience Prostate Specific Antigen (PSA) Biomarker Product and Solutions
2.5.4 Tosoh Bioscience Prostate Specific Antigen (PSA) Biomarker Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Tosoh Bioscience Recent Developments and Future Plans
2.6 Fujirebio
2.6.1 Fujirebio Details
2.6.2 Fujirebio Major Business
2.6.3 Fujirebio Prostate Specific Antigen (PSA) Biomarker Product and Solutions
2.6.4 Fujirebio Prostate Specific Antigen (PSA) Biomarker Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Fujirebio Recent Developments and Future Plans
2.7 BodiTech
2.7.1 BodiTech Details
2.7.2 BodiTech Major Business
2.7.3 BodiTech Prostate Specific Antigen (PSA) Biomarker Product and Solutions
2.7.4 BodiTech Prostate Specific Antigen (PSA) Biomarker Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 BodiTech Recent Developments and Future Plans
2.8 GE Healthcare
2.8.1 GE Healthcare Details
2.8.2 GE Healthcare Major Business
2.8.3 GE Healthcare Prostate Specific Antigen (PSA) Biomarker Product and Solutions
2.8.4 GE Healthcare Prostate Specific Antigen (PSA) Biomarker Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 GE Healthcare Recent Developments and Future Plans
2.9 Endocare
2.9.1 Endocare Details
2.9.2 Endocare Major Business
2.9.3 Endocare Prostate Specific Antigen (PSA) Biomarker Product and Solutions
2.9.4 Endocare Prostate Specific Antigen (PSA) Biomarker Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Endocare Recent Developments and Future Plans
2.10 Quest Diagnostics
2.10.1 Quest Diagnostics Details
2.10.2 Quest Diagnostics Major Business
2.10.3 Quest Diagnostics Prostate Specific Antigen (PSA) Biomarker Product and Solutions
2.10.4 Quest Diagnostics Prostate Specific Antigen (PSA) Biomarker Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Quest Diagnostics Recent Developments and Future Plans
2.11 Bio-Rad Laboratories
2.11.1 Bio-Rad Laboratories Details
2.11.2 Bio-Rad Laboratories Major Business
2.11.3 Bio-Rad Laboratories Prostate Specific Antigen (PSA) Biomarker Product and Solutions
2.11.4 Bio-Rad Laboratories Prostate Specific Antigen (PSA) Biomarker Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Bio-Rad Laboratories Recent Developments and Future Plans
2.12 QIAGEN
2.12.1 QIAGEN Details
2.12.2 QIAGEN Major Business
2.12.3 QIAGEN Prostate Specific Antigen (PSA) Biomarker Product and Solutions
2.12.4 QIAGEN Prostate Specific Antigen (PSA) Biomarker Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 QIAGEN Recent Developments and Future Plans
2.13 Myriad RBM
2.13.1 Myriad RBM Details
2.13.2 Myriad RBM Major Business
2.13.3 Myriad RBM Prostate Specific Antigen (PSA) Biomarker Product and Solutions
2.13.4 Myriad RBM Prostate Specific Antigen (PSA) Biomarker Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Myriad RBM Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Prostate Specific Antigen (PSA) Biomarker Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Prostate Specific Antigen (PSA) Biomarker Players Market Share
3.2.2 Top 10 Prostate Specific Antigen (PSA) Biomarker Players Market Share
3.2.3 Market Competition Trend
3.3 Prostate Specific Antigen (PSA) Biomarker Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Prostate Specific Antigen (PSA) Biomarker Revenue and Market Share by Type (2016-2021)
4.2 Global Prostate Specific Antigen (PSA) Biomarker Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Prostate Specific Antigen (PSA) Biomarker Revenue Market Share by Application (2016-2021)
5.2 Prostate Specific Antigen (PSA) Biomarker Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Prostate Specific Antigen (PSA) Biomarker Revenue by Type (2016-2026)
6.2 North America Prostate Specific Antigen (PSA) Biomarker Revenue by Application (2016-2026)
6.3 North America Prostate Specific Antigen (PSA) Biomarker Market Size by Country
6.3.1 North America Prostate Specific Antigen (PSA) Biomarker Revenue by Country (2016-2026)
6.3.2 United States Prostate Specific Antigen (PSA) Biomarker Market Size and Forecast (2016-2026)
6.3.3 Canada Prostate Specific Antigen (PSA) Biomarker Market Size and Forecast (2016-2026)
6.3.4 Mexico Prostate Specific Antigen (PSA) Biomarker Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Prostate Specific Antigen (PSA) Biomarker Revenue by Type (2016-2026)
7.2 Europe Prostate Specific Antigen (PSA) Biomarker Revenue by Application (2016-2026)
7.3 Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Country
7.3.1 Europe Prostate Specific Antigen (PSA) Biomarker Revenue by Country (2016-2026)
7.3.2 Germany Prostate Specific Antigen (PSA) Biomarker Market Size and Forecast (2016-2026)
7.3.3 France Prostate Specific Antigen (PSA) Biomarker Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Prostate Specific Antigen (PSA) Biomarker Market Size and Forecast (2016-2026)
7.3.5 Russia Prostate Specific Antigen (PSA) Biomarker Market Size and Forecast (2016-2026)
7.3.6 Italy Prostate Specific Antigen (PSA) Biomarker Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Revenue by Type (2016-2026)
8.2 Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Revenue by Application (2016-2026)
8.3 Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Market Size by Region
8.3.1 Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Revenue by Region (2016-2026)
8.3.2 China Prostate Specific Antigen (PSA) Biomarker Market Size and Forecast (2016-2026)
8.3.3 Japan Prostate Specific Antigen (PSA) Biomarker Market Size and Forecast (2016-2026)
8.3.4 South Korea Prostate Specific Antigen (PSA) Biomarker Market Size and Forecast (2016-2026)
8.3.5 India Prostate Specific Antigen (PSA) Biomarker Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Prostate Specific Antigen (PSA) Biomarker Market Size and Forecast (2016-2026)
8.3.7 Australia Prostate Specific Antigen (PSA) Biomarker Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Prostate Specific Antigen (PSA) Biomarker Revenue by Type (2016-2026)
9.2 South America Prostate Specific Antigen (PSA) Biomarker Revenue by Application (2016-2026)
9.3 South America Prostate Specific Antigen (PSA) Biomarker Market Size by Country
9.3.1 South America Prostate Specific Antigen (PSA) Biomarker Revenue by Country (2016-2026)
9.3.2 Brazil Prostate Specific Antigen (PSA) Biomarker Market Size and Forecast (2016-2026)
9.3.3 Argentina Prostate Specific Antigen (PSA) Biomarker Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Revenue by Type (2016-2026)
10.2 Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Revenue by Application (2016-2026)
10.3 Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Market Size by Country
10.3.1 Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Revenue by Country (2016-2026)
10.3.2 Turkey Prostate Specific Antigen (PSA) Biomarker Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Prostate Specific Antigen (PSA) Biomarker Market Size and Forecast (2016-2026)
10.3.4 UAE Prostate Specific Antigen (PSA) Biomarker Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Prostate Specific Antigen (PSA) Biomarker Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Prostate Specific Antigen (PSA) Biomarker Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Prostate Specific Antigen (PSA) Biomarker Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Prostate Specific Antigen (PSA) Biomarker Revenue (USD Million) by Region (2016-2021)
Table 5. Global Prostate Specific Antigen (PSA) Biomarker Revenue Market Share by Region (2021-2026)
Table 6. Abbott Corporate Information, Head Office, and Major Competitors
Table 7. Abbott Major Business
Table 8. Abbott Prostate Specific Antigen (PSA) Biomarker Product and Solutions
Table 9. Abbott Prostate Specific Antigen (PSA) Biomarker Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Siemens Healthcare Corporate Information, Head Office, and Major Competitors
Table 11. Siemens Healthcare Major Business
Table 12. Siemens Healthcare Prostate Specific Antigen (PSA) Biomarker Product and Solutions
Table 13. Siemens Healthcare Prostate Specific Antigen (PSA) Biomarker Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. DiaSorin Corporate Information, Head Office, and Major Competitors
Table 15. DiaSorin Major Business
Table 16. DiaSorin Prostate Specific Antigen (PSA) Biomarker Product and Solutions
Table 17. DiaSorin Prostate Specific Antigen (PSA) Biomarker Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Roche Corporate Information, Head Office, and Major Competitors
Table 19. Roche Major Business
Table 20. Roche Prostate Specific Antigen (PSA) Biomarker Product and Solutions
Table 21. Roche Prostate Specific Antigen (PSA) Biomarker Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Tosoh Bioscience Corporate Information, Head Office, and Major Competitors
Table 23. Tosoh Bioscience Major Business
Table 24. Tosoh Bioscience Prostate Specific Antigen (PSA) Biomarker Product and Solutions
Table 25. Tosoh Bioscience Prostate Specific Antigen (PSA) Biomarker Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Fujirebio Corporate Information, Head Office, and Major Competitors
Table 27. Fujirebio Major Business
Table 28. Fujirebio Prostate Specific Antigen (PSA) Biomarker Product and Solutions
Table 29. Fujirebio Prostate Specific Antigen (PSA) Biomarker Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. BodiTech Corporate Information, Head Office, and Major Competitors
Table 31. BodiTech Major Business
Table 32. BodiTech Prostate Specific Antigen (PSA) Biomarker Product and Solutions
Table 33. BodiTech Prostate Specific Antigen (PSA) Biomarker Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. GE Healthcare Corporate Information, Head Office, and Major Competitors
Table 35. GE Healthcare Major Business
Table 36. GE Healthcare Prostate Specific Antigen (PSA) Biomarker Product and Solutions
Table 37. GE Healthcare Prostate Specific Antigen (PSA) Biomarker Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Endocare Corporate Information, Head Office, and Major Competitors
Table 39. Endocare Major Business
Table 40. Endocare Prostate Specific Antigen (PSA) Biomarker Product and Solutions
Table 41. Endocare Prostate Specific Antigen (PSA) Biomarker Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Quest Diagnostics Corporate Information, Head Office, and Major Competitors
Table 43. Quest Diagnostics Major Business
Table 44. Quest Diagnostics Prostate Specific Antigen (PSA) Biomarker Product and Solutions
Table 45. Quest Diagnostics Prostate Specific Antigen (PSA) Biomarker Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Bio-Rad Laboratories Corporate Information, Head Office, and Major Competitors
Table 47. Bio-Rad Laboratories Major Business
Table 48. Bio-Rad Laboratories Prostate Specific Antigen (PSA) Biomarker Product and Solutions
Table 49. Bio-Rad Laboratories Prostate Specific Antigen (PSA) Biomarker Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. QIAGEN Corporate Information, Head Office, and Major Competitors
Table 51. QIAGEN Major Business
Table 52. QIAGEN Prostate Specific Antigen (PSA) Biomarker Product and Solutions
Table 53. QIAGEN Prostate Specific Antigen (PSA) Biomarker Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Myriad RBM Corporate Information, Head Office, and Major Competitors
Table 55. Myriad RBM Major Business
Table 56. Myriad RBM Prostate Specific Antigen (PSA) Biomarker Product and Solutions
Table 57. Myriad RBM Prostate Specific Antigen (PSA) Biomarker Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Global Prostate Specific Antigen (PSA) Biomarker Revenue (USD Million) by Players (2019-2021)
Table 59. Global Prostate Specific Antigen (PSA) Biomarker Revenue Share by Players (2019-2021)
Table 60. Breakdown of Prostate Specific Antigen (PSA) Biomarker by Company Type (Tier 1, Tier 2 and Tier 3)
Table 61. Prostate Specific Antigen (PSA) Biomarker Players Head Office, Products and Services Provided
Table 62. Prostate Specific Antigen (PSA) Biomarker Mergers & Acquisitions in the Past Five Years
Table 63. Prostate Specific Antigen (PSA) Biomarker New Entrants and Expansion Plans
Table 64. Global Prostate Specific Antigen (PSA) Biomarker Revenue (USD Million) by Type (2016-2021)
Table 65. Global Prostate Specific Antigen (PSA) Biomarker Revenue Share by Type (2016-2021)
Table 66. Global Prostate Specific Antigen (PSA) Biomarker Revenue Forecast by Type (2021-2026)
Table 67. Global Prostate Specific Antigen (PSA) Biomarker Revenue by Application (2016-2021)
Table 68. Global Prostate Specific Antigen (PSA) Biomarker Revenue Forecast by Application (2021-2026)
Table 69. North America Prostate Specific Antigen (PSA) Biomarker Revenue by Type (2016-2021) & (USD Million)
Table 70. North America Prostate Specific Antigen (PSA) Biomarker Revenue by Type (2021-2026) & (USD Million)
Table 71. North America Prostate Specific Antigen (PSA) Biomarker Revenue by Application (2016-2021) & (USD Million)
Table 72. North America Prostate Specific Antigen (PSA) Biomarker Revenue by Application (2021-2026) & (USD Million)
Table 73. North America Prostate Specific Antigen (PSA) Biomarker Revenue by Country (2016-2021) & (USD Million)
Table 74. North America Prostate Specific Antigen (PSA) Biomarker Revenue by Country (2021-2026) & (USD Million)
Table 75. Europe Prostate Specific Antigen (PSA) Biomarker Revenue by Type (2016-2021) & (USD Million)
Table 76. Europe Prostate Specific Antigen (PSA) Biomarker Revenue by Type (2021-2026) & (USD Million)
Table 77. Europe Prostate Specific Antigen (PSA) Biomarker Revenue by Application (2016-2021) & (USD Million)
Table 78. Europe Prostate Specific Antigen (PSA) Biomarker Revenue by Application (2021-2026) & (USD Million)
Table 79. Europe Prostate Specific Antigen (PSA) Biomarker Revenue by Country (2016-2021) & (USD Million)
Table 80. Europe Prostate Specific Antigen (PSA) Biomarker Revenue by Country (2021-2026) & (USD Million)
Table 81. Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Revenue by Type (2016-2021) & (USD Million)
Table 82. Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Revenue by Type (2021-2026) & (USD Million)
Table 83. Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Revenue by Application (2016-2021) & (USD Million)
Table 84. Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Revenue by Application (2021-2026) & (USD Million)
Table 85. Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Revenue by Region (2016-2021) & (USD Million)
Table 86. Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Revenue by Region (2021-2026) & (USD Million)
Table 87. South America Prostate Specific Antigen (PSA) Biomarker Revenue by Type (2016-2021) & (USD Million)
Table 88. South America Prostate Specific Antigen (PSA) Biomarker Revenue by Type (2021-2026) & (USD Million)
Table 89. South America Prostate Specific Antigen (PSA) Biomarker Revenue by Application (2016-2021) & (USD Million)
Table 90. South America Prostate Specific Antigen (PSA) Biomarker Revenue by Application (2021-2026) & (USD Million)
Table 91. South America Prostate Specific Antigen (PSA) Biomarker Revenue by Country (2016-2021) & (USD Million)
Table 92. South America Prostate Specific Antigen (PSA) Biomarker Revenue by Country (2021-2026) & (USD Million)
Table 93. Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Revenue by Type (2016-2021) & (USD Million)
Table 94. Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Revenue by Type (2021-2026) & (USD Million)
Table 95. Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Revenue by Application (2016-2021) & (USD Million)
Table 96. Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Revenue by Application (2021-2026) & (USD Million)
Table 97. Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Revenue by Country (2016-2021) & (USD Million)
Table 98. Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Prostate Specific Antigen (PSA) Biomarker Picture
Figure 2. Global Prostate Specific Antigen (PSA) Biomarker Revenue Market Share by Type in 2020
Figure 3. Blood
Figure 4. Semen
Figure 5. Urine
Figure 6. Prostate Specific Antigen (PSA) Biomarker Revenue Market Share by Application in 2020
Figure 7. Diagnostics Picture
Figure 8. Drug Discovery Picture
Figure 9. Personalized Medicine Picture
Figure 10. Others Picture
Figure 11. Global Prostate Specific Antigen (PSA) Biomarker Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global Prostate Specific Antigen (PSA) Biomarker Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global Prostate Specific Antigen (PSA) Biomarker Revenue Market Share by Region (2016-2026)
Figure 14. Global Prostate Specific Antigen (PSA) Biomarker Revenue Market Share by Region in 2020
Figure 15. North America Prostate Specific Antigen (PSA) Biomarker Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe Prostate Specific Antigen (PSA) Biomarker Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America Prostate Specific Antigen (PSA) Biomarker Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Middle East and Africa Prostate Specific Antigen (PSA) Biomarker Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Prostate Specific Antigen (PSA) Biomarker Market Drivers
Figure 21. Prostate Specific Antigen (PSA) Biomarker Market Restraints
Figure 22. Prostate Specific Antigen (PSA) Biomarker Market Trends
Figure 23. Abbott Recent Developments and Future Plans
Figure 24. Siemens Healthcare Recent Developments and Future Plans
Figure 25. DiaSorin Recent Developments and Future Plans
Figure 26. Roche Recent Developments and Future Plans
Figure 27. Tosoh Bioscience Recent Developments and Future Plans
Figure 28. Fujirebio Recent Developments and Future Plans
Figure 29. BodiTech Recent Developments and Future Plans
Figure 30. GE Healthcare Recent Developments and Future Plans
Figure 31. Endocare Recent Developments and Future Plans
Figure 32. Quest Diagnostics Recent Developments and Future Plans
Figure 33. Bio-Rad Laboratories Recent Developments and Future Plans
Figure 34. QIAGEN Recent Developments and Future Plans
Figure 35. Myriad RBM Recent Developments and Future Plans
Figure 36. Global Prostate Specific Antigen (PSA) Biomarker Revenue Share by Players in 2020
Figure 37. Prostate Specific Antigen (PSA) Biomarker Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 38. Global Top 3 Players Prostate Specific Antigen (PSA) Biomarker Revenue Market Share in 2020
Figure 39. Global Top 10 Players Prostate Specific Antigen (PSA) Biomarker Revenue Market Share in 2020
Figure 40. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 41. Global Prostate Specific Antigen (PSA) Biomarker Revenue Share by Type in 2020
Figure 42. Global Prostate Specific Antigen (PSA) Biomarker Market Share Forecast by Type (2021-2026)
Figure 43. Global Prostate Specific Antigen (PSA) Biomarker Revenue Share by Application in 2020
Figure 44. Global Prostate Specific Antigen (PSA) Biomarker Market Share Forecast by Application (2021-2026)
Figure 45. North America Prostate Specific Antigen (PSA) Biomarker Sales Market Share by Type (2016-2026)
Figure 46. North America Prostate Specific Antigen (PSA) Biomarker Sales Market Share by Application (2016-2026)
Figure 47. North America Prostate Specific Antigen (PSA) Biomarker Revenue Market Share by Country (2016-2026)
Figure 48. United States Prostate Specific Antigen (PSA) Biomarker Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Canada Prostate Specific Antigen (PSA) Biomarker Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Mexico Prostate Specific Antigen (PSA) Biomarker Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Europe Prostate Specific Antigen (PSA) Biomarker Sales Market Share by Type (2016-2026)
Figure 52. Europe Prostate Specific Antigen (PSA) Biomarker Sales Market Share by Application (2016-2026)
Figure 53. Europe Prostate Specific Antigen (PSA) Biomarker Revenue Market Share by Country (2016-2026)
Figure 54. Germany Prostate Specific Antigen (PSA) Biomarker Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. France Prostate Specific Antigen (PSA) Biomarker Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. United Kingdom Prostate Specific Antigen (PSA) Biomarker Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Russia Prostate Specific Antigen (PSA) Biomarker Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Italy Prostate Specific Antigen (PSA) Biomarker Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Sales Market Share by Type (2016-2026)
Figure 60. Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Sales Market Share by Application (2016-2026)
Figure 61. Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Revenue Market Share by Region (2016-2026)
Figure 62. China Prostate Specific Antigen (PSA) Biomarker Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Japan Prostate Specific Antigen (PSA) Biomarker Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South Korea Prostate Specific Antigen (PSA) Biomarker Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. India Prostate Specific Antigen (PSA) Biomarker Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Southeast Asia Prostate Specific Antigen (PSA) Biomarker Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Australia Prostate Specific Antigen (PSA) Biomarker Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. South America Prostate Specific Antigen (PSA) Biomarker Sales Market Share by Type (2016-2026)
Figure 69. South America Prostate Specific Antigen (PSA) Biomarker Sales Market Share by Application (2016-2026)
Figure 70. South America Prostate Specific Antigen (PSA) Biomarker Revenue Market Share by Country (2016-2026)
Figure 71. Brazil Prostate Specific Antigen (PSA) Biomarker Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Argentina Prostate Specific Antigen (PSA) Biomarker Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Middle East and Africa Prostate Specific Antigen (PSA) Biomarker Sales Market Share by Type (2016-2026)
Figure 74. Middle East and Africa Prostate Specific Antigen (PSA) Biomarker Sales Market Share by Application (2016-2026)
Figure 75. Middle East and Africa Prostate Specific Antigen (PSA) Biomarker Revenue Market Share by Country (2016-2026)
Figure 76. Turkey Prostate Specific Antigen (PSA) Biomarker Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Saudi Arabia Prostate Specific Antigen (PSA) Biomarker Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. UAE Prostate Specific Antigen (PSA) Biomarker Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Methodology
Figure 80. Research Process and Data Source

Table of Contents

Related reports :

(Sep 21)

The Thrombolytic Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentat...

(Sep 21)

The Image Guided and Robot Assisted Surgery market report provides a detailed analysis of global market size, regional and country-level mar...

(Sep 21)

The Medical Smart Textile market report provides a detailed analysis of global market size, regional and country-level market size, segmenta...

(Sep 21)

The Track-etched Membrane market report provides a detailed analysis of global market size, regional and country-level market size, segmenta...

(Sep 21)

The Therapeutic Drug Monitoring market report provides a detailed analysis of global market size, regional and country-level market size, se...

(Sep 21)

The Creatinine Measurement market report provides a detailed analysis of global market size, regional and country-level market size, segment...

Global Info Research

GLOBAL PROSTATE SPECIFIC ANTIGEN (PSA) BIOMARKER MARKET 2021 BY COMPANY, REGIONS, TYPE AND APPLICATION, FORECAST TO 2026

Share this report on:

Subscription Option


Using our subscription option, you get access to Market Research Reports and industry data of Medical Devices market as per your needs. Get the best of Medical Devices research reports by utilizing your research budgets in an optimum way. Contact for details

Contact for reports

*

We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy